Abstract
TNF inhibitors are being used in a rapidly expanding number of rheumatoid arthritis (RA) patients due to their effectiveness and acceptable safety profiles. To date, concerns regarding the adverse effects of TNF inhibitors have focused on infections, hematologic malignancies, and demyelinating disorders. Recently, the development of autoantibodies and other autoimmunity has been increasingly reported. Here, we describe a 36-year-old RA patient in whom organizing pneumonia and systemic lupus erythematosus were detected during etanercept treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Moreland LW, Weinblatt ME, Keystone EC et al (2006) Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience. J Rheumatol 33:854–861
Wolfe F, Michaud K (2004) Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50:1740–1751
Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44:2862–2869
Ramos-Casals M, Brito-Zeron P et al (2008) Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 22:847–861
Caramaschi P, Biasi D, Colombatti M et al (2006) Anti-TNF alpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 26:209–214
Moreland LW, Schiff MH, Baumgartner SW et al (1999) Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478–486
Schlesinger C, Koss MN (2005) The organizing pneumonias: an update and review. Curr Opin Pulm Med 11:422–430
Cordier JF (2006) Cryptogenic organising pneumonia. Eur Respir J 28:422–446
Mori S, Cho I, Koga Y, Sugimoto M (2008) A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 18:60–66
Kajiya T, Kuroda A, Hokonohara D, Tei C (2006) Radiographic appearance of bronchiolitis obliterans organizing pneumonia (BOOP) developing during Bucillamine treatment for rheumatoid arthritis. Am J Med Sci 332:39–42
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, SK., Oh, I.H., Park, C.K. et al. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int 32, 1055–1057 (2012). https://doi.org/10.1007/s00296-009-1350-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1350-4